Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data Ispire Technology Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2023
FY2023
FY2024
FY2025
FY2026
Revenue
88.1
116
152
127
96
Cost of revenue
74.8
94.8
122
105
83.7
Gross profit
13.3
20.8
29.8
22.6
12.3
Research and development
0.15
0.78
0.36
0.08
Selling and marketing
5.5
4.42
6.61
8.44
5.02
General and administrative
8.79
20.8
31.1
30
19.2
Operating expenses
14.3
25.3
43.7
60.5
44.9
Operating income
-0.99
-4.47
-13.9
-37.8
-32.6
Interest expense
3.33
0.19
0.37
Interest income
0.01
0.2
0.37
0.09
0.34
Other non-operating income
0.19
-0.28
0.41
-0.19
0.54
Pre-tax income
-0.8
-4.76
-13.5
-38
-32.1
Income tax
1.25
1.28
1.2
1.15
Net income
-1.87
-6
-14.8
-39.2
-33.2
EBITDA
-0.98
-4.43
-13.4
-37
-31.6
EPS, basic
-0.04
-0.12
-0.27
-0.69
-0.58
EPS, diluted
-0.04
-0.12
-0.27
-0.69
-0.58
Shares, basic (weighted)
50
50.7
54.8
56.9
57.3
Shares, diluted (weighted)
50
50.7
54.8
56.9
57.3
Balance sheet
FY2023
FY2023
FY2024
FY2025
FY2026
Cash and equivalents
74.5
40.3
35.1
24.4
19.3
Short-term investments
9.13
Receivables
8.26
24.5
59.7
39.6
19.8
Inventory
14.6
7.47
6.37
6.65
3.13
Other current assets
0.19
3.38
1.4
2.24
2.52
Total current assets
99.4
84.8
103
72.9
45.4
Property, plant and equipment
1.09
1.09
2.58
2.95
2.42
Lease right-of-use assets
0.3
4.25
3.58
5.03
3.03
Intangible assets
1.38
2.23
2.57
Other non-current assets
1.29
0.24
0.28
0.21
0.12
Total assets
101
90.4
123
102
64.3
Accounts payable
0.29
1.27
3.78
4.17
5.65
Accrued liabilities
0.03
0.04
1.01
1.18
0.77
Deferred revenue
1.67
0.99
2.22
4.86
1.89
Total current liabilities
89
55.9
86
72.5
44.6
Lease liabilities
3.07
2.19
3.27
1.89
Total liabilities
89
58.9
88.2
102
93.5
Paid-in capital
25.7
43.2
48.8
52.3
Retained earnings
11.9
5.94
-8.83
-48.1
-81.3
Treasury stock
-0.06
-0.06
Other comprehensive income
-0.16
0.06
-0.11
-0.2
Shareholders' equity
11.8
31.5
34.5
0.6
-29.2
Total equity
11.8
31.5
34.5
0.6
-29.2
Total liabilities and equity
101
90.4
123
102
64.3
Shares outstanding
50
54.2
56.5
57.2
57.6
Cash flow statement
FY2023
FY2023
FY2024
FY2025
FY2026
Net income
-1.87
-6
-14.8
-39.2
-33.2
Depreciation and amortization
0.01
0.05
0.51
0.81
0.94
Stock-based compensation
6.38
5.62
3.49
Deferred income tax
-0.09
Change in receivables
-3.95
-19.6
-41.3
-9.33
6.42
Change in inventory
-11.5
7.11
0.9
-1.04
0.7
Change in payables
8.88
10.6
17.9
10.8
Cash from operations
-7.56
-8.46
-18.3
-7.37
-0.57
Capital expenditures
-0.12
-1.02
-1.97
-1.1
-0.31
Purchases of investments
-9.13
-2
Cash from investing
-0.12
-10.2
2.99
-5.2
-3.08
Share buybacks
-0.06
-0.05
Dividends paid
-0.47
-3.36
Cash from financing
-3.09
-15.6
10.1
1.85
-1.32
Net change in cash
-10.8
-34.2
-5.23
-10.7
-4.97
Free cash flow
-7.68
-9.48
-20.3
-8.47
-0.88
Interest paid
0
0.02
0.15
0.37
Income taxes paid
1.66
1.36
1.53
1.61
Key metrics
Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $1.35 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
12.8%
Gross profit / revenue.
Operating margin
-33.9%
Operating income / revenue.
EBITDA margin
-33.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-33.4%
Pre-tax income / revenue.
Net margin
-34.6%
Net income / revenue.
FCF margin
-0.9%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-0.6%
Cash from operations / revenue.
Return on assets (ROA)
-39.9%
Net income / average total assets.
R&D / revenue
0.1%
Research and development expense / revenue.
Stock-based pay / revenue
3.6%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.3%
Capital expenditures / revenue.
D&A / revenue
1.0%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-24.7%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-6.0%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y
-45.7%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-16.0%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y
-4,937.0%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-37.1%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-10.7%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y
0.8%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
4.1%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.02x
Current assets / current liabilities.
Quick ratio
0.88x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.43x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.58
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$0.58
Net income per basic share, as reported (split-adjusted).
Revenue per share
$1.68
Revenue / diluted weighted shares.
FCF per share
-$0.02
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.01
Cash from operations / diluted weighted shares.
Book value per share
-$0.51
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.81x
Market cap / revenue.
EV/Sales
0.61x
Enterprise value / revenue.
FCF yield
-1.1%
Free cash flow / market cap.
Earnings yield
-42.8%
Net income / market cap (the inverse of P/E).
Shareholder yield
0.1%
(Dividends paid + share buybacks) / market cap.
What was Ispire Technology Inc.'s revenue in fiscal 2026?
Ispire Technology Inc. reported revenue of $96.0M for fiscal 2026, 24.7% lower than the year before.
Was Ispire Technology Inc. profitable in fiscal 2026?
No. It reported a net loss of $33.2M.
How much free cash flow did Ispire Technology Inc. generate in fiscal 2026?
Cash from operations of $569.4K minus capital expenditures of $306.0K left free cash flow of -$875.4K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.